Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Other financing activities (2024)

Foghorn Therapeutics has reported Other financing activities over the past 1 years, most recently at $390000.0 for Q3 2024.

  • Quarterly results put Other financing activities at $390000.0 for Q3 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $390000.0 (changed 0.0% YoY), and the annual figure for FY2024 was $585000.0, changed.
  • Other financing activities for Q3 2024 was $390000.0 at Foghorn Therapeutics.
  • Over the last five years, Other financing activities for FHTX hit a ceiling of $390000.0 in Q3 2024 and a floor of $390000.0 in Q3 2024.